About Us

Our mission is to empower people living with neuromuscular diseases to live longer, more independent lives.

Press Releases

Dec 11, 2013

MDA Awards Second 'Bridge-to-Industry' Grant
Nov 13, 2013

Halo Therapeutics Receives $500,000 MDA Award to Develop Drug for Duchenne Muscular Dystrophy
Nov 11, 2013

RE: FDA Says That New Drug Application Filing for Eteplirsen is Premature
Oct 9, 2013

Press Release: Drug for Duchenne Muscular Dystrophy Successfully Completes Phase 1 Trial; Trial in Boys with DMD May Be Next
Jun 18, 2013

Sarepta Therapeutics Announces Eteplirsen Demonstrates a Continued Benefit on Walking Test through 84 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy
Apr 16, 2013

ARMGO Pharma Receives $1 Million MDA Award to Continue Development of Novel DMD Treatment

Find MDA
in your Community